Cargando…
Hepatic ROS Mediated Macrophage Activation Is Responsible for Irinotecan Induced Liver Injury
Irinotecan is the first line chemotherapy drug used for treatment of metastatic colorectal cancer worldwide. There is increasing evidence suggesting that liver damage, including steatosis and steatohepatitis, can be caused during the treatment involving irinotecan. However, molecular mechanisms by w...
Autores principales: | Liu, Bohao, Ding, Cong, Tang, Wenbin, Zhang, Chen, Gu, Yiying, Wang, Zhiqiang, Yu, Tingzi, Li, Zhuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9739808/ https://www.ncbi.nlm.nih.gov/pubmed/36497051 http://dx.doi.org/10.3390/cells11233791 |
Ejemplares similares
-
Hepatic Macrophages in Liver Injury
por: Shan, Zhao, et al.
Publicado: (2020) -
Neutrophils promote the development of reparative macrophages mediated by ROS to orchestrate liver repair
por: Yang, Wenting, et al.
Publicado: (2019) -
Hepatic macrophage mediated immune response in liver steatosis driven carcinogenesis
por: Tu, Taojian, et al.
Publicado: (2022) -
Dual Effect of Hepatic Macrophages on Liver Ischemia and Reperfusion Injury during Liver Transplantation
por: Lu, Tian-Fei, et al.
Publicado: (2018) -
Contribution of HIF-1α/BNIP3-mediated autophagy to lipid accumulation during irinotecan-induced liver injury
por: Shi, Congjian, et al.
Publicado: (2023)